Cell Theranostics Leadership

Scientific Advisory Board

F. David Rollo, M.D., PH.D., FACC, FACNP

Dr. Rollo joined Cell>Point in September 2006 and now serves aa a consultant to the company. Prior to Cell>Point, Dr. Rollo was Chief Medical Officer for Philips Medical Systems (now Philips Healthcare). Prior to joining Philips, Dr. Rollo served as Senior Vice President for Medical Affairs and Executive Medical Director for Raytel Medical Corporation from June 1996 to October 1999. Raytel owned and managed 15 outpatient diagnostic imaging centers and two hospital-based cardiovascular centers. From January 1995 to June 1996, Dr. Rollo served as Senior Vice President for Medical Affairs of HCIA following the sale of his ownership in Metricor (a healthcare company that had been spun off from Humana to HCIA). Metricor was a provider of quality management and clinical outcome services, technology assessment and asset management services and billing, coding and collections consulting services. During this same period of time, Dr. Rollo served as President of Managed Medical Imaging, a company specializing in outsourcing management of diagnostic imaging services for hospitals. With Humana, Dr. Rollo served as Chief Medical Officer and as Senior Vice President for Medical Affairs. He was also the founding Medical Director of the Humana Health Plans. He has received nearly 60 awards, honors and grants and has held over 40 professional appointments. Dr. Rollo’s clinical and research activities focused on non-invasive diagnostic procedures to include echocardiography, nuclear imaging, PET imaging, digital angiography and vascular imaging for CT and MRI. Dr. Rollo’s education includes a Master of Science in Radiological Physics from University of Miami, a Ph.D. in Physics from the Johns Hopkins Medical Institutions and an M.D. from Upstate Medical Center in Syracuse. Dr. Rollo is a Fellow of the American College of Cardiology, a Fellow of the American College of Nuclear Physicians, is Board Certified by the American Board of Nuclear Medicine and Cardiology. Dr. Rollo has served on the Board of Directors of 11 companies, five of which went public.